News from micurx pharmaceuticals, inc

Dec 19, 2013, 23:00 ET

MicuRx Expands Global Clinical Trial Program For Oral Antibiotic MRX-I

 MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced the...

Aug 22, 2013, 05:00 ET

MicuRx Completes $25 Million Series B Financing

MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced it raised $25...

Oct 24, 2012, 09:20 ET

MicuRx and Shanghai Zhangjiang Biomedical Industry Venture Capital Partner to Develop Next-generation Antibiotic MRX-I for Chinese Market

 MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, and Shanghai Zhangjiang...

May 23, 2012, 05:00 ET

MicuRx Pharmaceuticals Announces Issuance Of U.S. Patent For Its Next-Generation Antibacterial Agent

MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced that the U.S....

Apr 23, 2012, 03:01 ET

MicuRx Pharmaceuticals Completes Phase 1 Trial For MRX-I, A Next-Generation Antibiotic

 MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced the...

Apr 06, 2010, 15:00 ET

MicuRx Pharmaceuticals and Cumencor Pharmaceuticals Partner with Pfizer to Discover and Develop Antibiotics for Drug-Resistant Tuberculosis in China

MicuRx Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of antibiotics to treat drug-resistant bacteria, and...

Mar 15, 2010, 08:00 ET

MicuRx Pharmaceuticals Files Investigational New Drug Application for MRX-I

MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced that it has filed...

Aug 18, 2008, 01:00 ET

MicuRx Pharmaceuticals Selects Next-Generation Antibiotic Candidate Targeting MRSA and Expands Operation in China

UNION CITY, Calif. and SHANGHAI, China, Aug. 18 /PRNewswire-FirstCall/ -- MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical...

Jun 25, 2007, 01:00 ET

MicuRx Pharmaceuticals Completes $10 Million Series A Financing to Fund Discovery and Development of Next-Generation Antibiotics

UNION CITY, Calif., June 25 /PRNewswire/ -- MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company today announced the...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer